Involvement of AP-1 in p38MAPK signaling pathway in osteoblast apoptosis induced by high glucose
Z P Feng1, H C Deng2, R Jiang2
1Department of Endocrinology, The First Affiliated Hospital, Chongqing Medical University, Chongqing, China fengzhengping_f@yeah.net.
Abstract:
We investigated the effect of p38MAPK/AP-1 (activator protein-1) signaling on the apoptosis of osteoblasts induced by high glucose. A lentivirus vector of small hairpin RNA (shRNA) targeting p38MAPK was constructed in vitro. Osteoblasts MC3T3-E1 cultured in vitro were treated with vehicle, high glucose, p38MAPK-shRNA transfection, p38MAPK inhibitor, and unrelated shRNA transfection. Apoptosis, protein levels of p38MAPK, and activities of AP-1 in MC3T3-E1 osteoblasts were measured using TUNEL and flow cytometry, Western blot analysis, and an electrophoretic mobility shift assay. Compared with the vehicle group, high glucose induced apoptosis of MC3T3-E1 osteoblasts and activated p38MAPK and AP-1. p38MAPK-shRNA transfection blocked the effect of high glucose stimulation, and the p38MAPK inhibitor showed similar effects as those observed in p38MAPK transfection. Unrelated shRNA had no effect on these changes in MC3T3-E1 osteoblasts induced by high glucose. Therefore, our results suggest that p38MAPK-shRNA reduce apoptosis of MC3T3-E1 osteoblasts induced by high glucose by inhibiting the p38MAPK-AP-1 signaling pathway.
Insights
High glucose induces osteoblast apoptosis via p38MAPK/AP-1 signaling. Inhibiting this pathway with p38MAPK-shRNA reduces high glucose-induced osteoblast apoptosis, offering a potential therapeutic target.
Area of Science:
- Cell Biology
- Molecular Biology
- Biochemistry
Background:
- High glucose levels are implicated in various cellular dysfunctions.
- Osteoblast apoptosis contributes to bone pathologies.
- The p38 mitogen-activated protein kinase (MAPK) and activator protein-1 (AP-1) signaling pathway plays a role in cellular stress responses.
Purpose of the Study:
- To investigate the role of the p38MAPK/AP-1 signaling pathway in high glucose-induced osteoblast apoptosis.
- To determine if inhibiting p38MAPK can mitigate high glucose-induced osteoblast apoptosis.
Main Methods:
- Osteoblasts (MC3T3-E1) were cultured and treated with high glucose, p38MAPK-shRNA, p38MAPK inhibitor, or control.
- Apoptosis was assessed using TUNEL and flow cytometry.
- Protein levels of p38MAPK and AP-1 activity were measured via Western blot and electrophoretic mobility shift assay, respectively.
Main Results:
- High glucose significantly induced apoptosis in MC3T3-E1 osteoblasts.
- High glucose treatment activated both p38MAPK and AP-1 signaling.
- p38MAPK-shRNA transfection and p38MAPK inhibitor treatment effectively blocked high glucose-induced apoptosis and pathway activation.
- Unrelated shRNA had no significant effect.
Conclusions:
- The p38MAPK-AP-1 signaling pathway is critically involved in high glucose-induced osteoblast apoptosis.
- Inhibition of the p38MAPK-AP-1 pathway represents a potential strategy to reduce high glucose-induced osteoblast apoptosis.
More Related Videos
09:37A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation
Published on: March 15, 2018
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway
The Intrinsic Apoptotic Pathway
MAPK Signaling Cascades
cAMP-dependent Protein Kinase Pathways
Cell Specific Gene Expression
